Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Asmanex Twisthaler

Known as: Twisthaler, Asmanex 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
INTRODUCTION Mometasone furoate (MF) is the inhaled corticosteroid (ICS) component in the long-acting β2-agonist (LABA)/ICS fixed… Expand
2019
2019
Introduction GINA 2019 recommends LABA/ICS as preferred controller therapy in patients with inadequately controlled asthma… Expand
2018
2018
The patients’ inhalation flow pattern is one of the significant determinants for clinical performance of inhalation therapy… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
2014
2014
Background QMF149 is an investigational inhaled fixed-dose combination of indacaterol acetate (long-acting β 2 -agonist) and… Expand
2012
2012
Background: QMF149 is being developed as a fixed dose combination of the long-acting β 2 -agonist indacaterol and the inhaled… Expand
2012
2012
SummaryAbstractInhaled mometasone furoate (Asmanex®) is a synthetic corticosteroid indicated for the first-line maintenance… Expand
  • table I
  • table II
  • figure 1
2007
2007
Inhaled corticosteroids (ICS) are recommended as the standard treatment for children with persistent asthma. However, compliance… Expand